Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
No Longer Available No phase listed Expanded access

ZYESAMI (Aviptadil) Intermediate Population Expanded Access Protocol (SAMICARE)

ClinicalTrials.gov ID: NCT04453839

Public ClinicalTrials.gov record NCT04453839. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 12:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ZYESAMI (Aviptadil) Intermediate Population Expanded Access Protocol

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Patients with Critical COVID-19 and respiratory failure who are ineligible for enrollment in NCT04311697, who live more than 50 miles from an existing collaborating research center, or who are already hospitalized and cannot safely be transferred to a collaborating research facility may be considered for expanded access by the sponsor. Treating physicians must complete FDA Form 3396 and receive a letter of authorization from NeuroRx, along with local IRB authorization. Please refer to FDA guidance for Individual Patient Expanded Access https://www.fda.gov/media/91160/download

Study identification

NCT ID
NCT04453839
Recruitment status
No Longer Available
Study type
Expanded access
Phase
Not listed
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years to 100 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Feb 2, 2023

United States locations

U.S. sites
25
U.S. states
12
U.S. cities
23
Facility City State ZIP Site status
Dignity Health-Mercy Gilbert Medical Center Gilbert Arizona 85297
Honor Health Shea Medical Center Scottsdale Arizona 85260
Kaiser Permanente Baldwin Park California 91706
University of California - Irvine Irvine California 92697
Lawnwood Regional Medical Center Ft. Pierce Florida 34950
Lakeland Regional Health Lakeland Florida 33805
Miller School of Medicine / University of Miami Medical Center Miami Florida 33136
Baptist Hospital of Miami Miami Florida 33176
Baycare St. Joseph Hospital Tampa Florida 33607
Southeast Georgia Health system Brunswick Georgia 31520
Maui Health Systems Wailuku Hawaii 96793
St. Anthony Regional Hospital Carroll Iowa 51401
University of Louisville Louisville Kentucky 40202
St. Tammany Parish Hospital Covington Louisiana 70433
Our Ladies of Lourdes Regional Hospital Lafayette Louisiana 70508
St. Joseph Heritage Healthcare Saint Joseph Missouri 64506
Great Plains Health North Platte Nebraska 69101
Self Regional Healthcare Greenwood South Carolina 29646
Hendrick Medical Center Abilene Texas 79601
Baptist Hospitals of Southeast Texas Beaumont Texas 77701-4689
Medical City Denton Denton Texas 76210
HR Health Institute for Research & Development Edinburg Texas 78539
Houston Methodist Hospital Houston Texas 77030
Memorial Hermann Hospital Houston Houston Texas 77030
Medical City McKinney McKinney Texas 75609

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04453839, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 2, 2023 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04453839 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →